12:2212:22, 14 January 2018diffhist+1
Arkangel (Black Mirror)
→Plot: Just added a space for my prior edit. Clicked to fast in earlier edit: I agree that in the end the filter breaks and she can see what she did to her mother. So I propose to keep that part of the previous edit, as it is correct.Tags: Mobile editMobile web edit
23:3523:35, 27 December 2017diffhist+278
N
User:Wowbagger2
←Created page with ' I provide quant input for decision making in drug development for Bayer, oncology business unit. Simply spoken: I am a statistician. {{User male}} {{User:Will...'Tags: Mobile editMobile web edit
14:4114:41, 27 December 2017diffhist+17
Duvelisib
→See also: Added Copanlisib in addition to Idelalisib (both are approved, with Copanlisib being a pan-class inhibitor, as Duvelisib is).Tags: Mobile editMobile web edit
13:1113:11, 23 December 2017diffhist+198
Entrectinib
→Clinical development: Replaced link to commercial website for StarTrek2 trial with the clinicaltrials.gov page. This ensures unbiased information, a generic approach to citing studies and clinical trials.gov also supports recruitment of patients in...Tags: Mobile editMobile web edit
14:1314:13, 15 December 2017diffhist+406
Copanlisib
Switched from Chem to Drugbox; Added details into Drugbox; Replaced commercial name with INN; Small furhter edits in the main text
12:2212:22, 14 January 2018diffhist+1
Arkangel (Black Mirror)
→Plot: Just added a space for my prior edit. Clicked to fast in earlier edit: I agree that in the end the filter breaks and she can see what she did to her mother. So I propose to keep that part of the previous edit, as it is correct.Tags: Mobile editMobile web edit
23:3523:35, 27 December 2017diffhist+278
N
User:Wowbagger2
←Created page with ' I provide quant input for decision making in drug development for Bayer, oncology business unit. Simply spoken: I am a statistician. {{User male}} {{User:Will...'Tags: Mobile editMobile web edit
14:4114:41, 27 December 2017diffhist+17
Duvelisib
→See also: Added Copanlisib in addition to Idelalisib (both are approved, with Copanlisib being a pan-class inhibitor, as Duvelisib is).Tags: Mobile editMobile web edit
13:1113:11, 23 December 2017diffhist+198
Entrectinib
→Clinical development: Replaced link to commercial website for StarTrek2 trial with the clinicaltrials.gov page. This ensures unbiased information, a generic approach to citing studies and clinical trials.gov also supports recruitment of patients in...Tags: Mobile editMobile web edit
14:1314:13, 15 December 2017diffhist+406
Copanlisib
Switched from Chem to Drugbox; Added details into Drugbox; Replaced commercial name with INN; Small furhter edits in the main text